Use of strains of the parapox ovis virus against organ fibrosis
CA 2415399 C · Owner: Knorr, Andreas · Inventors: Theiss, Gudrun; Schlapp, Tobias; Siegling, Angela
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the use in humans, of inactivated , parapoxviruses for the prophylaxis and treatment of diseases which are accompanied by an increased , deposition of collagen, with it being possible for both internal organs such , as the , liver, and the skin and its appended structures to be affected. The invention , relates in particular, to liver fibrosis and/or liver cirrhosis consequent upon virus hepatitis, or , to ethanol-induced liver diseases and to cystic fibrosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 11, 2001 and granted November 8, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 11, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 11, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.